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Arsenic-72 (72As; 2.49 MeV positron, 26 h) and 77As (0.683 MeV beta particle, 38.8 h) have nuclear
properties useful for positron emission tomography (PET) and radiotherapy applications. Their half-lives are
sufficiently long for targeting tumors with peptides and antibodies. Potential radioarsenic
radiopharmaceuticals require identification of suitable bifunctional chelates for development of compounds
stable under in vivo conditions at high dilution. The thiophilic nature of arsenic led to the synthesis and
characterization of aryl arsenite dithiolate precursors to no-carrier added 72,77As complexes. Additionally,
the synthesis and no-carrier added labelling of a simple trithiol ligand with 77As, and synthesis of two
linkable trithiocyanate precursors, a carboxylic acid, and “clickable” alkyne, are described in detail.  
